MedPath

Intraoperative OCT Guidance of Intraocular Surgery II

Recruiting
Conditions
Preretinal Fibrosis
Macular Holes
Epiretinal Membrane
Cataract
Strabismus
Healthy
Retinal Detachment
Diabetic Retinopathy
Retinal Disease
Ocular Tumor
Registration Number
NCT03713268
Lead Sponsor
Duke University
Brief Summary

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
262
Inclusion Criteria
  1. Healthy controls: Healthy eyes without known disease: refractive error including myopia and non-significant cataract is allowed. For selected testing pseudophakia is allowed.
  2. Surgeons as research subjects: Adult (≥18 years old)
  3. Surgical patients (vitreoretinal surgery): Patients undergoing examination under anesthesia or surgery for vitreoretinal diseases
  4. Surgical patients (anterior segment surgery-glaucoma, ocular surface or strabismus requiring extraocular muscle surgery): Include both adults and children. Patient undergoing primary, elective minimally invasive glaucoma surgery, ocular surface surgery, or strabismus surgery.
Exclusion Criteria
  1. Healthy controls: Any ocular disease that restricts the ability to perform OCT scanning. Conflict of interest with investigators/study personnel, e.g. a student in the lab of an investigator.
  2. Surgeons as research subjects: no specific exclusion criteria.
  3. Surgical patients (vitreoretinal surgery): Neonates (< 4 weeks of age) and patients with any ocular disease that restricts the ability to perform OCT scanning.
  4. Surgical patients (anterior segment surgery-corneal and cataract diseases): Pediatric patients: The cornea and cataract surgery studies will be restricted to adults (≥ 18 years). Children do not have cataract surgery typically by residents and therefore would not fit our study design. Similarly pediatric corneal transplants are very rare.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of retinal and/or corneal microscope integrated optical coherence tomography image captureYear 1

Quality of MIOCT images scored based on standard microanatomy and ability to detect presence or absence of ocular pathologies based on review by a masked grader.

Retinal vascular flow on optical coherence tomography angiography (OCTA) versus fluorescein angiographyYear 1

Cross correlation of ability to capture vessels and vessel pathology between OCTA and fluorescein angiographic images.

Retinal and/or corneal microscope integrated optical coherence tomography image captureYear 1

Ability to capture images

Assessment of change in pattern of ocular vascular flow before and after standard clinical surgical steps.Year 1

Presence or absence of change in ocular morphology in pattern of vascular flow compared to prior to surgical steps

Assessment of change in ocular morphology before and after standard surgical stepsYear 1

Presence or absence of change in ocular morphology before and after standard surgical steps

Estimate of subretinal fluid volume before and after surgery for retinal detachment based on surgical view versus based on OCT outputYear 1

Volume estimates from surgeons analyzed relative to the postoperative calculated volume from the intraoperative MIOCT

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Duke University Eye Center

🇺🇸

Durham, North Carolina, United States

Duke University Eye Center
🇺🇸Durham, North Carolina, United States
Michelle McCall
Contact
919-684-0544
mccal023@mc.duke.edu
Neeru Sarin
Contact
9196685641
neeru.sarin@duke.edu
Cynthia A Toth, MD
Principal Investigator
Anthony Kuo, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.